Latest Breaking News On - David gamm - Page 1 : vimarsana.com

FUJIFILM Cellular Dynamics and Opsis Therapeutics Announce License with BlueRock Therapeutics for iPSC-derived Cell Therapy Candidate

Science stories that stood out on campus in 2023

Eyestem Research hosts India's First Retinal Cell and Gene Therapy Summit at inStem

bharti: Affordable gene and cell therapies need of the hour: Dr Kapil Bharti, Scientific Director, National Eye Institute

Limitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.

UW researchers will trial gene editing therapy to treat blindness

From concussions to PFAS: five ways UW research is tackling real-world problems

Do hPSC-derived retinal neurons possess intrinsic potential to form new synaptic connections after extraction from organoids?

Researchers successfully demonstrated that lab-grown retinal organoids made new synaptic connections, theoretically establishing their potential to treat blindness due to retinal degenerative diseases.

Lab-Grown Retinas May Restore Vision to People With Damaged Eyes

Researchers have developed a method for producing retina-like organoids that could aid in reconnection even after separation.

Lab-Grown Retinas to Restore Vision Are a Step Closer to Human Trials

Scientists from the University of Wisconsin–Madison in the US have coaxed light-sensitive eye cells grown in a lab to reconnect after separation, an important step for transplantation into patients to treat various eye diseases.

Scientists Create Retinas in the Lab that May One Day Treat Eye Diseases

Lab-grown retinas produced by scientists may one day treat eye diseases as they advance with their work.